Is ALGN or ANGO more undervalued in 2026?

CirclFi compares Align Technology, Inc. (ALGN) and AngioDynamics, Inc. (ANGO) using 13 institutional-grade valuation models. ALGN has a Quality of Company score of 9.2/10 while ANGO scores 6.5/10.

Which is a better buy — ALGN or ANGO?

Compare intrinsic values from 13 independent models against current market prices. CirclFi also calculates Value Trap scores. This is not financial advice — conduct your own analysis.

How do ALGN and ANGO valuations compare?

ALGN at $174.95 and ANGO at $11.48 are compared across Bayesian DCF, EPV, EROIC Spread, First Chicago, Markov DDM, and 8 additional models.

ALGN vs ANGO Valuation Comparison 2026 — Intrinsic Value Analysis

ALGN

Medical Instruments & Supplies

Align Technology, Inc.

Quality

9.2

out of 10

Value Trap

LOW

Price

$174.95

Last close

Models

13/13

Active

ANGO

Medical Instruments & Supplies

AngioDynamics, Inc.

Quality

6.5

out of 10

Value Trap

SAFE

Price

$11.48

Last close

Models

12/13

Active

Model-by-Model Comparison

Model	Type	ALGN Fair Value	ALGN Upside	ANGO Fair Value	ANGO Upside
Bayesian DCF	Intrinsic	$123.79	-29.2%	$2.67	-76.7%
Earnings Power Value	Intrinsic	$54.68	-68.7%	$26.31	+129.1%
EROIC Spread	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
First Chicago	Scenario	$•••.••	••.•%	$•••.••	••.•%
Markov DDM	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
ML-RIV	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
Dynamic NAV	Asset-Based	$•••.••	••.•%	$•••.••	••.•%
PWERM	Option-Based	$•••.••	••.•%	$•••.••	••.•%
Regime Cross-Sectional	Relative	$•••.••	••.•%	$•••.••	••.•%
Sentiment SOTP	Hybrid	$•••.••	••.•%	$•••.••	••.•%
CUCE Ensemble	Ensemble	$•••.••	••.•%	$•••.••	••.•%
FTNN Topology	Relative	$•••.••	••.•%	$•••.••	••.•%
RCMH-DCF	Intrinsic	$•••.••	••.•%	$•••.••	••.•%

🔒

Unlock Full 13-Model Comparison

Access all valuation models for ALGN vs ANGO — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

ALGN vs ANGO — Which Stock Is More Undervalued?

ALGN scores higher with a 9.2/10 quality rating vs ANGO's 6.5/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing Align Technology, Inc. (ALGN) and AngioDynamics, Inc. (ANGO) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

ALGN currently trades at $174.95 with a QOC of 9.2/10, while ANGO trades at $11.48 with a QOC of 6.5/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).